More More Create medical devices that meet the ever-developing needs of practitioners and researchers.

These materials are commonly used in injection molding, blow molding, film extrusion and other plastics processes. Our diagnostic experts can help with analysis and testing related to early stage development for medical devices More

Featured Articles More More

Investor Day POLYONE I N V E S T O R P R E S E N T A T I O N A U G U S T 2 0 1 8 FORWARD LOOKING STATEMENTS PolyOne Corporation 2 USE OF NON-GAAP MEASURES PolyOne Corporation 3 V I S I O N PolyOne Corporation 4 To be the world’s premier provider of specialized polymer materials, services and solutions C O R E V A L U E S P E R S O N A L V A L U E S Honesty IntegrityRespect Operational Excellence Commercial Excellence Specialization Globalization Collaboration ExcellenceInnovation To be the world’s premier provider of specialized polymer materials, services and solutions S A F E T Y F I R S T PolyOne Corporation 5 1.3 1.1 1.1 0.85 0.65 0.57 0.54 0.97 0.84 0.74 0.74 0.69 0.57 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 YTD Injuries per 100 Workers Spartech Acquisition PolyOne Corporation 6 P O L Y O N E 2 0 1 7 R E V E N U E | $ 3 . 2 B I L L I O N 9% United States 59% 14% 10% Latin America 9% Canada PolyOne Distribution 34% Performance Products & Solutions 21% Specialty Engineered 19% Color Additives & Inks 26% Segment End Market Geography Building & Construction Electrical & Electronics 2009 2010 2011 2012 2013 2014 2015 2016* 2017* P R O O F O F P E R F O R M A N C E C O N S E C U T I V E Y E A R S PolyOne Corporation 7 8 $0.13 $0.68 $0.82 $1.00 $1.31 $1.80 $1.96 $2.06 $2.21 “Where we were” “Where we are” ROIC** 5.0% 14.0% Operating Income % of Sales Color, Additives & Inks 1.7% 15.5% Specialty Engineered Materials 1.1% 12.1% Performance Products & Solutions 4.3% 10.7% Distribution 2.6% 6.3% A D J U S T E D E P S E X P A N S I O N S U S T A I N A B L E P A T H T O D O U B L E - D I G I T E P S G R O W T H PolyOne Corporation 8 P E O P L E P R O D U C T S P L A N E T P E R F O R M A N C E Double digit annual EPS growth strategic acquisitions Innovate 600K-1M commercial resources 6-8% Double acquired Lean Six Sigma commercial excellence 531 689130 157 504 633 2014 Q2 2018 R&D / Technical Marketing Sales PolyOne Corporation 9 Increased commercial headcount + 28% + 18% + 23% Generating opportunities 35% 25% 1,000 $1.0B Enhancing efficiency I N V E S T M E N T I N COMMERCIAL RESOURCES D R I V I N G G R O W T H Lead Specialists T H E E V O L V I N G C U S T O M E R R E L A T I O N S H I P PolyOne Corporation 10 Expanded Path Traditional Path Strategic Accounts/ Field Sales Business Development Customer Service Web and Social Media Inside Sales PolyOne Corporation 11 Investments in digital and dedicated inside sales to improve customer experience 80% increase in leads (from 6,000 to 11,000) driven by website, phone, and online chat EXPANDED PATH A D D I N G C U S T O M E R T O U C H P O I N T S 4 21 Inside sellers $11M $88M Inside sales/digital revenue N E W R E S O U R C E S F U E L I N G T H E F U T U R E PolyOne Corporation 12 P O L Y O N E S A L E S F U N N E L +34% $3.0 billion 2017 $4.0 billion A L I G N I N G W I T H T R E N D S F O R G R O W T H T R A N S P O R T A T I O N P A C K A G I N G H E A L T H C A R E C O N S U M E R PolyOne Corporation 13 Facilitate alternative energy solutions Light- weighting Reduce packaging materials Improve recyclability Reduce spread of infection I N N O V A T I O N PolyOne Corporation 14 Customization 55% M&A 30% Innovation Pipeline Innovation comes from Research & Development Spend Vitality Index 38% $20 $52 Transformational Adjacent Core 3 H O R I Z O N S O F D E V E L O P M E N T PolyOne Corporation 15 Market Technical I N N O V A T I O N I N N O V A T I O N P I P E L I N E PolyOne Corporation 16 PrototypeFrame Opportunity Scale-up & Test Market Build Business Case Commercial Launch (since 2015) Phase 1 Phase 2 Phase 3 Phase 4 Phase 5 8 6 2 1 15 4 10 11 4 7 Breakthrough Platform Derivative F L A M E R E T A R D A N T P O L Y M E R S A D V A N C E D C O M P O S I T E S B A R R I E R M A T E R I A L S C O L O R A N T T E C H N O L O G I E S T H E R M O P L A S T I C E L A S T O M E R S I N N O V A T I O N S P O T L I G H T : C O M P O S I T E S PolyOne Corporation 17 C O M P O S I T E S R E F R E S H E R PolyOne Corporation 18 Fiber Polymer Composite S T R A T E G I C I N V E S T M E N T H I S T O R Y Thermoplastic Composites Long Fiber Reinforced Thermoplastics Continuous Fiber Thermosets Long Fiber Reinforced Thermoplastics Continuous Fiber Thermosets 2012 2015 20162009 2011 2018 PolyOne Corporation 19 C O M P O S I T E S I N T R A N S P O R T A T I O N PolyOne Corporation 20 W A T E R C R A F TR A I L H E A V Y T R U C K PolyOne Corporation 21 Safety Technology Geography Service FinancialPeople 8-10% with ability to double I N V E S T - T O - G R O W M & A S T R A T E G Y PolyOne Corporation 22 Capture sourcing synergies Cross-sell & blend technology 8-10% operating I N V E S T - T O - G R O W M & A P L A Y B O O K Protect customers Retain employees Implement LSS to drive efficiency improvements Innovate with combined portfolio Safety First! Leverage PolyOne’s global reach Phase 1 Phase 2 Phase 3 18-20% operating Invest in commercial resources I N V E S T - T O - G R O W P R O O F O F P E R F O R M A N C E PolyOne Corporation 23 Commercial Resources Operating Income ($ in millions) Operating Margins 243 335 $36 $90 Established Acquisitions (> 7 years) + 40% + 150% + 900 bps I N V E S T - T O - G R O W D R I V I N G T H E F U T U R E PolyOne Corporation 24 Commercial Resources Operating Income ($ in millions) Operating Margins 113 144 206 $16 $18 $60 7% 8% 18-20% Recent Acquisitions PolyOne Corporation 25 Average Company Size # of Possibilities Rationale $200M S T R O N G P I P E L I N E D R I V E N B Y F R A G M E N T E D M A R K E T $0 $150 $300 $450 $600 $750 2011 2012 2013 2014 2015 2016 2017 2018 $809M R E T U R N I N G C A S H T O S H A R E H O L D E R S O V E R $ 1 B I L L I O N S I N C E 2 0 1 1 PolyOne Corporation $0.16 $0.20 $0.24 $0.32 $0.40 $0.48 $0.58 $0.70 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 3-Year Dividend Plan Cumulative Share Repurchases Increasing Annual Dividend 26 6.3% 14.0% 15.0% 16-17% 2009 2017 Platinum Vision Updated Expectations R O I C D R I V E S S H A R E H O L D E R R E T U R N PolyOne Corporation 27 PolyOne Corporation 28 W H Y I N V E S T I N P O L Y O N E ? T H E N E W P O L Y O N E : A S P E C I A L T Y G R O W T H C O M P A N Y SERVICE: T H E T I M E L E S S D I F F E R E N T I A T O R PolyOne Corporation 29 T A L E N T D E V E L O P M E N T PolyOne Corporation 30 Leadership Program Participants 2012 2013 2015 47 86 2016 2018 125 169 315 Campus Hires 2008 2011 2017 25 90 47 PolyOne LSS Blackbelts 2008 2011 2018 67 220 147 2018 141 A U N I Q U E C U S T O M E R E X P E R I E N C E Industrial Design IQ DESIGN LABS PolyOne Corporation 31 Material & Color Expertise Manufacturing Expertise 3 14 Industrial designers $0 $7M $4M $40M Opportunity funnel New business revenue LSS CUSTOMER FIRST PolyOne Corporation 32 Customer Projects 2 85 3 D P R I N T I N G B R I N G I N G N E W I D E A S T O L I F E PolyOne Corporation 33 PolyOne Corporation 34 99.9% up to 24 weeks 6 hours C O L O R M A T R I X S E L E C T ™ I N N O V A T I N G W I T H P O L Y O N E PolyOne Corporation 35 SEGMENT HIGHLIGHTS C O L O R , A D D I T I V E S & I N K S PolyOne Corporation 36 Solid Colorants Performance Additives Screen Printing Inks Liquid Colorants 27% 14% Textiles Building & 10% 10%Transportation Electrical & Operating Income & MarginRevenue by Region C O L O R , A D D I T I V E S & I N K S 2 0 1 7 R E V E N U E | $ 8 9 3 M I L L I O N $4 $25 $104 $139 0.9% 5.5% 12.2% 15.5% PolyOne Corporation 37 32% 46% 1% Mexico Brazil S P E C I A L T Y E N G I N E E R E D M A T E R I A L S PolyOne Corporation 38 Engineered Formulations Advanced Composites Thermoplastic Elastomers 19% 13% Building & Electrical & S P E C I A L T Y E N G I N E E R E D M A T E R I A L S Revenue by Region Operating Income & Margin 2 0 1 7 R E V E N U E | $ 6 2 4 M I L L I O N PolyOne Corporation 39 $21 $57 $76 0.1% 5.1% 9.3% 28% 48% 22% 12.1% P E R F O R M A N C E P R O D U C T S & S O L U T I O N S PolyOne Corporation 40 Specialty Vinyl Solutions Healthcare Formulations Smart Device Flame Retardant Polymers Building & 30% Electrical & 1% Asia 77% Mexico P E R F O R M A N C E P R O D U C T S & S O L U T I O N S Operating Income & MarginRevenue by Region 2 0 1 7 R E V E N U E | $ 7 2 1 M I L L I O N $40 $33 $56 $77 4.6% 3.6% 7.2% 10.7% PolyOne Corporation 41 $886 $668 $773 $721Sales D I S T R I B U T I O N E N D M A R K E T S & S U P P L I E R S PolyOne Corporation 42 23% 22% Electrical & Building & $20 $25 $63 $73 2.9% 4.0% 5.9% 6.3% Operating Income & Margin2017 Revenue | $1.2 Billion http://www.polyone.com/Pages/VariationRoot.aspx T A R G E T E N D M A R K E T S & A P P L I C A T I O N E X A M P L E S PolyOne Corporation 43 Thermally Conductive Chemical Resistant Polymer Colorants Elastomeric Grips and Handles Structural Composites Antimicrobial Technologies Anti-Counterfeiting Target End Markets… Healthcare Catheter Technologies Under-hood Components Target End Markets… Automotive Interior Structural Sound & Vibration Management Roof Systems Air Management Electronics and Cameras Lighting Exterior / Interior Trim Braces & Brackets Fasteners Seals & Flaps Target End Markets… Consumer Thermally Conductive Polymer Colorants Elastomeric Grips and Handles Structural Composite Oxygen Scavenger Laser Marking Additives Antistatic Technologies UV Light Barrier Technologies Cap & Closure Colorants Process Optimization Antioxidant Technologies Density Modified Target End Markets… Packaging Luxury Packaging GravitechTM Density Modified Polymers Optimize Color Usage OnColorTM Super Concentrates Combat Bacteria Formation WithStandTM Antimicrobial Technology Medical Device Housings Chemically Resistant Engineered Polymers Color & Design Services Outdoor Applications Fiber Colorants Smart Home Devices ResilienceTM Vinyl Solutions � � �������� � � ��� � �� � ����� ����� ��� ��� ������ �� ��� ��� �� ��� ��� !"

Contact Avient for more information. Without limiting the generality of this statement, Avient products shall not be used in any medical device application intended for: (1) exposure to human tissue or body fluids for 30 days or greater; (2) “plastic” (cosmetic or reconstructive) surgery use; (3) reproductive implants or any birth control device; or (4) any critical component in a permanently (greater than 30 days) implanted medical device that supports or sustains human life. It is the responsibility of the medical device manufacturer and the person placing the medical device on the market to ensure compliance of the medical device, including the suitability of all raw materials and components used for its manufacture, and with all applicable laws and regulations. 1.844.4AVIENT www.avient.com

SPECIALTY SOLUTION BOOSTS PRODUCTIVITY FOR MEDICAL HOSE MANUFACTURER CASE STUDY: VERSALLOY™ THERMOPLASTIC VULCANIZATE Challe nge Accepted. MATERIAL REDUCES COSTS WITH LOWER SPECIFIC GRAVITY, AND HIGHER FLOW THAN COMPETITIVE TPV © 2021, All Rights Reserved Avient Corporation, 33587 Walker Road, Avon Lake, Ohio USA 44012 To learn more about Versalloy™ Thermoplastic Vulcanizate, contact Avient at +1.844.4AVIENT (1.844.428.4368) or visit avient.com. THE IMPACT Avient’s expertise in materials for medical device applications helped this customer make a smooth transition to the GLS TPV.

Featured Articles More More

The devices, in turn, rely on materials that limit signal loss at high-band 5G frequencies (mmWave). Featured Articles More

The company noted its materials enable food, beverage and medical supplies to continue to be produced, packaged, shipped and used.  This includes masks, protective garments, medical tubing and packaging for personal care products.  For more information, visit www.polyone.com

MEDICAL DEVICE MANUFACTURER D I S P O S A B L E M E D I C A L T R A Y • Excellent wear resistance that can sustain a minimum of 2,000 rotations • Withstand freezing temperature as low as -20°C • Can be sterilized by EtO • Delivered excellent wear resistance performance to fully meet customer’s request • Provided dimensional stability required for this medical application • Reduced friction to lower the noise during operation LubriOne™ Internally Lubricated Formulation KEY REQUIREMENTS WHY AVIENT? AVIENT SOLUTION WEAR RESISTANCE + DIMENSIONAL STABILITY LEARN MORE Copyright © 2022, Avient Corporation.